Noventi's bold restructuring saves it from collapse and secures market dominance
Noventi has completed a major restructuring effort, saving the company from financial collapse. The programme, launched in 2022, stabilised operations and secured a stronger market position in pharmaceutical IT and billing systems.
The company's 'Focus 2025' initiative included cutting costs, streamlining products, and selling off subsidiaries. Locations were closed, and efficiency measures were introduced to reduce spending. By early 2026, these changes helped Noventi grow its market share from around 25% to over 35%, making it the industry leader.
Noventi also secured a consortium credit agreement with Deutsche Apotheker- und Ärztebank (Apobank). This financial support strengthened the company's stability and allowed for future planning. CEO Mark Bühm credited employees, customers, and the FSA for their combined effort in turning the business around.
Andreas Buck, Chairman of the FSA and Deputy Chairman of the Supervisory Board, called the restructuring a 'Herculean task' but praised the team's unity. Holger Wessling, Chairman of the Supervisory Board, highlighted the dedication of staff and management in building a profitable future. CFO Frank Steimel expressed pride in the company's new financial foundation and thanked refinancing partners for their role.
Looking ahead, Noventi plans to invest in modernising its IT infrastructure by 2030. Strategic funding will also go toward product development and internal improvements.
The restructuring has positioned Noventi as a market leader in pharmaceutical IT solutions. With a stronger financial base and clear investment plans, the company now focuses on long-term growth and stability.
Read also:
- Federal Funding Supports Increase in Family Medicine Residency Program, Focusing on Rural Health Developments
- Potential Role of DHA in Shielding the Brain from Saturated Fats?
- Alternative Gentle Retinoid: Exploring Bakuchiol Salicylate for Sensitive Skin
- Hanoi initiates a trial program for rabies control, along with efforts to facilitate the transition from the dog and cat meat trade industry.
